UK offers genomic sequencing capacity and capability to Pakistan

Through the New Variant Assessment Platform (NVAP) programme Pakistan will be able to draw on UK expertise and support to detect quickly new, and potentially more dangerous, variants of COVID-19.

The UK is a world leader in genomic sequencing for COVID variants and the second largest contributor to the international database for the variants. Through an agreement reached between UK’s Public Health England (PHE) and Pakistan’s National Institute for Health (NIH), the UK will share its expertise and provide reagents to increase genomic sequencing capacity in Pakistan. The support will also include technical advice on bio-informatics workflow and technical processes.

The British High Commissioner to Pakistan, Dr Christian Turner said:

Sharing world class UK science expertise with Pakistan will help detecting new COVID variants of concern and keep fighting this pandemic.

This shows the best of UK-Pakistan friendship and our commitment to back Pakistan in building back better from the impacts of COVID-19.

Background

the New Variant Assessment Platform (NVAP) is a programme announced by the Secretary of State for Health in January 2021. Its aim is to offer UK support globally for SARS-CoV-2 new variant identification to countries that wish to monitor the variants circulating in their population, but do not themselves have the capability to identify these variants

strong surveillance, including genomics, is key to identifying and controlling the transmission of the virus. UK support through the NVAP will provide valuable information to other countries, allowing them to strengthen their own genomic surveillance

NVAP is led by PHE and will be taken forward by the UK Health Security Agency, working closely with the Department for Health and Social Care and the Foreign, Commonwealth & Development Office

NVAP will collaborate with key scientific partners both within the UK and across the world

the UK has strong scientific links globally which are being leveraged in developing the programme

the UK is committed to equitable access to vaccines globally. At the G7, the UK announced it will donate 100 million vaccines for the world. This is in addition to our £548 million funding for COVAX which will provide vaccines for free to over 90 countries, including Pakistan

UK science helped the development of the Oxford-University AstraZeneca vaccine; and we are funding a new centre in the UK that will play a key role in controlling zoonotic diseases and protecting the livelihoods of farmers

the UK has pivoted £18 million of UK aid in Pakistan to help save lives and mitigate the against the health and economic impacts of the pandemic

Contact

Press Office

British High Commission, Islamabad

tel. +92 300 5005306

For further information

For updates on the British High Commission, please follow our social media channels:

Twitter: @UKinPakistan, @CTurnerFCO

Facebook: facebook.com/bhcpakistan

Instagram: @UKinPakistan

#UKPAKDosti